---
title: Publications
---

import useBaseUrl from '@docusaurus/useBaseUrl';

# Publications
<br />

The Quantitative Proteomics Core (QPC) supports proteomics studies across basic, translational, and clinical research.
Publications below include projects supported by QPC at varying levels of involvement, from study design and data generation to analysis and interpretation.

> **Note:** Representative figures are shown to illustrate proteomics outputs and workflows. Figures are credited to the original publications and licenses.

---

## Representative figures by workflow
<br />

These examples are curated to showcase what QPC enables across key proteomics applications (proteome, interactome, clinical, spatial).
Expand each entry to view a short description and a representative panel.

### Proteome analysis

<details>
<summary><b>ZBTB48 is a priming factor regulating B-cell-specific CIITA expression</b> — Rane <i>et al.</i>, <i>The EMBO Journal</i> (2024)</summary>

<br />

<div style={{ display: 'flex', justifyContent: 'center', margin: '0.4rem 0 0.8rem' }}>
  <img
    src={useBaseUrl('img/4-qpc-pub-proteome-2024-volcano.png')}
    alt="Figure 3F: IFNγ treated U2OS WT vs ZBTB48 KO proteome"
    style={{ width: '82%', maxWidth: '900px', height: 'auto', display: 'block' }}
  />
</div>

**Why this figure:** Example of quantitative proteome comparison (WT vs KO) under IFNγ stimulation, highlighting regulated proteins (volcano plot).

**QPC contribution:** Quantitative proteomics support and analysis as part of the study’s proteomics component.

- **Link / DOI:** https://doi.org/10.1038/s44318-024-00306-y
- **Figure credit:** Rane G. <i>et al.</i>, The EMBO Journal (2024), Fig. 3F. Used under **CC BY 4.0** (cropped).  
  License: https://creativecommons.org/licenses/by/4.0/

</details>

<!-- Add more Proteome examples here (3–6 max) -->

---

### Interactome analysis (IP-MS / ChIP-MS / proximity)

<details>
<summary><b>ZBTB48-dependent chromatin composition revealed by ChIP-MS</b> — Yong <i>et al.</i>, <i>bioRxiv</i> (2023)</summary>

<br />

<div style={{ display: 'flex', justifyContent: 'center', margin: '0.4rem 0 0.8rem' }}>
  <img
    src={useBaseUrl('img/4-qpc-pub-chipms-2023-volcano.png')}
    alt="ZBTB48 WT vs KO ChIP-MS volcano plot"
    style={{ width: '82%', maxWidth: '900px', height: 'auto', display: 'block' }}
  />
</div>

**Research summary:**  
This study applied chromatin immunoprecipitation coupled to label-free quantitative mass spectrometry (ChIP-MS) to characterize proteins associated with ZBTB48 at telomeric regions.

A wild-type versus ZBTB48 knockout comparison was used as a genetic control to distinguish ZBTB48-dependent chromatin-associated proteins from background binding. This approach enables specific interrogation of telomere locus-associated protein composition using ChIP-MS.

**Why this figure:** Representative example of ChIP-MS using genetic knockout controls to demonstrate specificity of chromatin-associated protein enrichment.

**QPC contribution:** Experimental design, ChIP-MS workflow optimisation, quantitative proteomics analysis, and data interpretation.

- **Link / DOI:** https://www.biorxiv.org/content/10.1101/2023.01.27.525999v1  
- **Figure credit:** Yong W.K. <i>et al.</i>, bioRxiv (2023). Adapted from published figures.
</details>

<details>
<summary><b>[Paper title]</b> — [First author] <i>et al.</i>, <i>[Journal]</i> ([Year])</summary>

<br />

**Workflow showcased:** IP-MS / ChIP-MS / BioID / APEX / etc.  
**Key readout:** [1 line — e.g., interaction network / enriched complex / binding partners]

- **Link / DOI:** [link]
- **Figure credit:** [if you include figure, add license/permission statement]

</details>

<!-- Add 3–6 Interactome examples -->

---

### Clinical / translational proteomics

<details>
<summary><b>[Paper title]</b> — [First author] <i>et al.</i>, <i>[Journal]</i> ([Year])</summary>

<br />

**Clinical context:** [serum / plasma / tissue / FFPE / biopsy]  
**Proteomics strategy:** [label-free / TMT / DIA / fractionation / etc.]

- **Link / DOI:** [link]

</details>

---

### Spatial / Imaging MS

<details>
<summary><b>[Paper title]</b> — [First author] <i>et al.</i>, <i>[Journal]</i> ([Year])</summary>

<br />

**Spatial approach:** MALDI imaging / IHC-MS / etc.  
**Tissue context:** [cancer type / organ]

- **Link / DOI:** [link]

</details>

---

## Selected publications
<br />

This section highlights a broader set of strong collaborative studies involving QPC (not necessarily with a figure shown). Keep entries concise.

### 2025
- **[First author]**, [co-authors]. *[Title]*. **[Journal]** (2025). https://doi.org/xxxxx
- **[First author]**, [co-authors]. *[Title]*. **[Journal]** (2025). https://doi.org/xxxxx

### 2024
- **Rane G**, Kuan VLS, Wang S, *et al.* *ZBTB48 is a priming factor regulating B-cell-specific CIITA expression.* **The EMBO Journal** (2024). https://doi.org/10.1038/s44318-024-00306-y
- **[First author]**, [co-authors]. *[Title]*. **[Journal]** (2024). https://doi.org/xxxxx

### 2023
- **[First author]**, [co-authors]. *[Title]*. **[Journal]** (2023). https://doi.org/xxxxx
